ConductScience.org, home

Paper3922282

gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy.

Gram L and 2 others. Ann Neurol, 1985. Cited by 162 papers, by iCite.

Cite this record

ConductScience Library. gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy. Papers, record 3922282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3922282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy.
PubMed
Journal
Ann Neurol
PubMed
Year
1985
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
162
iCite
Relative citation ratio, by iCite
8.79
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gram LL
2Klosterskov PP
3Dam MM

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminocaproatesMajor topic
AnticonvulsantsMajor topic
Epilepsies, PartialMajor topic
Adolescent
Adult
Clinical Trials as Topic
Double-Blind Method
Evoked Potentials
Female
Humans
Male
Middle Aged
Vigabatrin

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.

PMIDTitleJournalYearIn PapersSource
32730657Vigabatrin add-on therapy for drug-resistant focal epilepsy.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/32730657PubMed
29556176Conflicting Effects of Methylglyoxal and Potential Significance of miRNAs for Seizure Treatment.Front Mol Neurosci2018https://conductscience.org/library/papers/29556176PubMed
25391707Drug-induced cerebellar ataxia: a systematic review.CNS Drugs2014https://conductscience.org/library/papers/25391707PubMed
23683707Molecular mechanisms of antiseizure drug activity at GABAA receptors.Seizure2013https://conductscience.org/library/papers/23683707PubMed
20842588New antiepileptic drugs: lacosamide, rufinamide, and vigabatrin.Curr Treat Options Neurol2010https://conductscience.org/library/papers/20842588PubMed
19851518Treatment of refractory complex partial seizures: role of vigabatrin.Neuropsychiatr Dis Treat2009https://conductscience.org/library/papers/19851518PubMed
11665869A risk-benefit assessment of treatments for infantile spasms.Drug Saf2001https://conductscience.org/library/papers/11665869PubMed
10915031Adverse reactions to new anticonvulsant drugs.Drug Saf2000https://conductscience.org/library/papers/10915031PubMed
10765970Visual electrophysiological effect of a GABA transaminase blocker.Doc Ophthalmol1998https://conductscience.org/library/papers/10765970PubMed
8896946Pharmacokinetic interactions of the new antiepileptic drugs.Clin Pharmacokinet1996https://conductscience.org/library/papers/8896946PubMed
8089668Effects of vigabatrin on partial seizures and cognitive function.J Neurol Neurosurg Psychiatry1994https://conductscience.org/library/papers/8089668PubMed
8037889A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.Drug Saf1994https://conductscience.org/library/papers/8037889PubMed
7917080Newer antiepileptic drugs. Towards an improved risk-benefit ratio.Drug Saf1994https://conductscience.org/library/papers/7917080PubMed
7586896The role of therapeutic drug monitoring in improving the cost effectiveness of anticonvulsant therapy.Clin Pharmacokinet1995https://conductscience.org/library/papers/7586896PubMed
7528126Evaluation of antiepileptic drug efficacy. A review of clinical trial design.Drugs1994https://conductscience.org/library/papers/7528126PubMed
3683730Stereoselective uptake of the GABA-transaminase inhibitors gamma-vinyl GABA and gamma-acetylenic GABA into neurons and astrocytes.Neurochem Res1986https://conductscience.org/library/papers/3683730PubMed
3358887Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug.Br J Clin Pharmacol1988https://conductscience.org/library/papers/3358887PubMed
2757901Vigabatrin in the treatment of epilepsy in children.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2757901PubMed
2667606A multicentre study of vigabatrin for drug-resistant epilepsy.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2667606PubMed
2667603Response to vigabatrin in relation to seizure type.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2667603PubMed

See all 31 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABAT18PubTator's text mininghttps://conductscience.org/library/genes/18

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3922282

GET https://conductscience.org/api/papers/v1/3922282/cited_by?page=2